With the best-selling osteoporosis drug Fosamax on trial amid allegations that it causes “jaw death” in patients, you might think healthcare consumers would rejoice at the prospect of a new alternative to Fosamax on the market.
You might think that — until you look at the price.
The new drug, Amgen’s Prolia (denosumab), is up for approval by an FDA advisory committee this week. The aspect of Prolia that has received the most attention is that it is a product of biotechnology. It is a new class of drug, a “fully human monoclonal antibody” designed to target a protein that causes bone loss.
Studies indicate that it works as well as or slightly better than Fosamax and other bisphosphonates, such as Actonel and Boniva.
The Los Angeles Times reports:
The drug “does everything you would want a drug to do in women to prevent fractures,” said Dr. John S. Adams, an orthopedic surgeon at UCLA’s Geffen School of Medicine…
“This appears to be the most potent of the osteoporosis drugs,” [said Dr. Frederick R.] Singer … director of the endocrine/bone disease program at John Wayne Cancer Institute in Santa Monica.
That’s the good news. Now the bad news: the price.
Amgen, the manufacturer of denosumab, has not said how much the drug will cost, but analysts expect it to be at least $2,000 a year — and potentially much higher — and predict yearly sales of $2 billion to $3 billion.
Already, many insurance companies are pushing physicians to the generic version of Fosamax, alendronate, which costs about $100 a year.
Keep in mind also that, in all likelihood, insurance companies will not cover Prolia with a simple copay, but instead will require patients to pay for a significant percentage of the cost of the drug out of pocket.
The backstory here is that Amgen has been touting Prolia as a new “blockbuster drug” to Wall Street for some time now. And Wall Street has rewarded Amgen handsomely. As BusinessWeek reports:
Wall Street has set an exceptionally high bar for Amgen (AMGN)’s new bone-loss treatment. Shares of the world’s largest biotechnology company have jumped 27% in the past three months, to 60, largely on news of clinical trials that showed the drug is as at least as effective, and sometimes better, than standard osteoporosis treatments when it comes to preventing and treating dangerous fractures.
Wall Street is expecting a windfall, and Amgen will price Prolia to deliver that windfall. Which means the drug won’t be such a windfall for healthcare consumers.
-
-
Search Blog Posts
-
Save Even More Money!
-
-
Trending Content
-
Watch our YouTube Video
-
Categories
Big Pharma Buy prescriptions online Canadian drugs Drug costs Drug reimportation Drug safety eDrugSearch.com FDA Health 2.0 Healthcare100 Healthcare blogs Healthcare solutions Low-cost drugs Medicare Part D Merck Online pharmacies Online pharmacy safety Pfizer Pharma bloggers Pharmaceutical companies Pharmaceutical marketing Pharma cheerleaders Prescription drug abuse Prescription drug prices Prescription drugs Prescriptions Wal-Mart drug plan -
Blogroll
- Bullet Wisdom
- Bulverde Business Directory
- Christian Counseling San Antonio Tx.
- Christian Schools in San Antonio Texas
- Christian Social Network
- Christians United for Israel
- DrugWonks.com
- Eye on FDA
- GoozNews
- Health 2.0
- Hunting Forum
- In the Pipeline
- Jesus Christ Our King
- John Hagee Ministries
- Kevin, M.D.
- Local Search Marketing
- My $299 Website
- Pharm Aid
- Pharma Marketing
- PharmaGossip
- Pharmalot
- San Antonio Asphalt
- San Antonio Life Insurance
- San Antonio Pressure Washing
- Storage New Braunfels Tx
- Texas Wildlife Supply
- The Angry Pharmacist
- The Health Care Blog
- The Peter Rost Blog
- World Vision
-
Tags
big pharma Canadian drugs canadian pharmacies canadian pharmacy consumer reports craig newmark divine healing Drug costs drug prices Drug reimportation eDrugSearch.com FDA Fosamax Generic drugs healing scriptures Health 2.0 healthcare reform Hypertension Jehova Rophe Jesus Christ Lipitor Metformin miracles nabp online pharmacy dictionary online prescriptions osteoporosis peter rost Pharmacies pharmacists pharmacychecker pharmacy spam phrma Prescription drugs prescription medication Proverbs 3:5-8 reimportation relenza Roche saving money SSRI swine flu Tamiflu The Great Physician The Lord our Healer -
Recent Tweets
- eDrugSearch Blog Rank on the Healthcare100: http://t.co/VJprL4LZWl [#]
- New blog posting, How to Get Prescription Medication Without Health Insurance - http://t.co/1ZdLavB87d [#]
- 10 Tips for Safer Prescription Drug Use http://t.co/GFnMIN1mCy [#]
- New blog posting, How to Beat High Drug Prices By Comparing Low Cost Pharmacies - http://t.co/fsZ0stNZme [#]
-
Archives
-
Recent Comments
- Heather Sturges on What is the Difference Between Effexor and Cymbalta?
- Lupe Machol on Cost of diabetes drugs has nearly doubled
- Manpower For Hospital In Pune on Why is Medicine Cheaper in Canada?
- Jen on How a Canadian Pharmacy Can Help You Offset Drug Price Hikes
- nino iarajuli on Vending machine dispenses prescription drugs